Disruption of ZBTB7A/LRF or BCL11A binding site in healthy donor and B-thalassemia /HbE patient
Amplicon Deep Sequencing of On-Target gamma-Genome Editing and Off-Target Effects at -197 ZBTB7A/LRF or -115 BCL11A in healthy donor and Beta-Thalassemia/HbE Patients